InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the complete record of transactions filed by Durgam Suresh K., Directeur Médical. Officer active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 7 disclosures have been published. Breakdown: 0 buy · 3 sells. Total volume traded: €672k. Activity tracked since 18 January 2022. The latest transaction was filed on 2 March 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
4,177 shares@ US$56.9831.8% of flowCommon StockSEC:0001209191-22-016447:0
7,906 sharesCommon StockSEC:0001209191-22-013363:0
8,354 sharesCommon StockSEC:0001209191-22-012396:0
6,223 shares@ US$42.03100.0% of flowCommon StockSEC:0001209191-22-004015
6,223 shares@ US$42.0334.1% of flowCommon StockSEC:0001209191-22-004015:0
13,093 sharesCommon StockSEC:0001209191-22-002993
13,093 sharesCommon StockSEC:0001209191-22-002993:0
7 of 7 declarations
About Durgam Suresh K.
Suresh K. Durgam is the Chief Medical Officer at Intra-Cellular Therapies, Inc. In this role, he oversees the company's clinical and research activities, ensuring that the products developed meet safety and efficacy standards. Suresh plays a key role in guiding the strategic direction of research and development initiatives. His medical expertise is essential for the success of the organization's clinical projects.
